ContributorsPublishersAdvertisers

Cleveland Clinic Launches Trial Examining Preventive Vaccine for TNBC

onclive.com
 2021-12-02

Cleveland Clinic has partnered with Anixa Biosciences, Inc. to open a phase 1 trial examining a vaccine aimed at preventing the development of triple-negative breast cancer. Cleveland Clinic has partnered with Anixa Biosciences, Inc. to open a phase 1 trial examining a vaccine aimed at preventing the development of triple-negative breast...

www.onclive.com

Comments / 0

Comments / 0